MIODx Licenses Key Immunotherapy Technologies from UCSF – Yahoo Finance
|
MIODx Licenses Key Immunotherapy Technologies from UCSF
Yahoo Finance SAN JOSE, Calif., Feb. 23, 2017 /PRNewswire/ — MIODx announced today that it has signed an exclusive license for two key immunotherapy technologies from the University of California, San Francisco (UCSF). The first technology provides a method to … |
